secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2026-01-06T23:59:59+00:00
Accession:  0001493152-26-000518
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspire Biopharma converts ~$1.75M debt from PowerUp sponsors into common stock
------------------------------------------------------------------------------

- Exchanged ~$1.75M debt for common stock at closing price less $0.01/share; holders can submit up to 4 exchange notices by Jan 31, 2026.
- Each exchange notice limited to 30% of outstanding balance; shares are freely tradeable without restrictive legends.
- Upon a financing over $3M, company may repay debt; holder can elect 25% of outstanding balance from proceeds.
- Exchange exempt under Section 3(a)(9) of Securities Act; debt originated from 2024 subscription agreements with PowerUp sponsors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226000518/0001493152-26-000518-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226000518/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-000518

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer